Mindwave Medical, Inc. has recently filed an amendment to its previous offering of securities, which could indicate a shift in its fundraising strategy. This development is significant as it may influence how companies within the medical technology sector approach capital raising.
Mindwave Medical, Inc. is a company focused on developing innovative medical technologies. According to its SEC filings, the company is categorized under the entity type 'other' and has a Central Index Key (CIK) of 0002066912. The latest filing, dated October 26, 2026, is an amendment (D/A) to a prior offering.
The filing states that it is a Notice of Exempt Offering of Securities and includes the item number 06b. However, specific details regarding the changes made in this amendment were not available in the SEC filing.
This amendment may impact various stakeholders, including potential investors and competitors in the medical technology field. Companies in this sector often look to similar filings for guidance on fundraising and investment strategies.
The filing does not say what happens next, leaving the future steps of Mindwave Medical, Inc. unclear.
Company Details
Mindwave Medical, Inc. has a mailing and business address located at 9111 Cross Park Drive, Knoxville, TN 37923. The company can be reached at the phone number 865-284-1004. It is incorporated in Delaware and has an Employer Identification Number (EIN) of 333733915.
The fiscal year for Mindwave Medical, Inc. ends on December 31st, which is relevant for understanding its financial reporting cycles and potential timing for future offerings or announcements.
Filing Specifics
The amendment, classified under Item 06b of Form D/A, indicates that it is a Notice of Exempt Offering of Securities. The filing was accepted on the same day it was submitted, October 26, 2026, and it became effective immediately.
"The filing does not include specific changes made in this amendment, nor does it elaborate on the terms of the offering or the intended use of the raised capital."